Zynex, Inc. (ZYXI)
NASDAQ: ZYXI · Real-Time Price · USD
2.250
-0.180 (-7.41%)
Mar 28, 2025, 4:00 PM EDT - Market closed
Zynex Employees
Zynex had 1,000 employees as of December 31, 2024. The number of employees decreased by 100 or -9.09% compared to the previous year.
Employees
1,000
Change (1Y)
-100
Growth (1Y)
-9.09%
Revenue / Employee
$192,354
Profits / Employee
$2,994
Market Cap
71.80M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ZYXI News
- 2 days ago - INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Zynex - PRNewsWire
- 3 days ago - Wolf Haldenstein informs investors that Zynex, Inc. has been sued - PRNewsWire
- 9 days ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Zynex, Inc. (ZYXI) And Encourages Stockholders to Connect - Accesswire
- 10 days ago - Zynex, Inc. (ZYXI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - Accesswire
- 11 days ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Zynex, Inc. (ZYXI) and Encourages Stockholders to Learn More About the Investigation - Accesswire
- 12 days ago - Bronstein, Gewirtz & Grossman, LLC Encourages Zynex, Inc. (ZYXI) Investors to Inquire about Securities Investigation - Accesswire
- 13 days ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Zynex, Inc. (ZYXI) And Encourages Investors to Reach Out - Accesswire
- 18 days ago - Zynex's Sell-Off Creates A Speculative Buying Opportunity - Seeking Alpha